Karen M. Dobos - Publications

Affiliations: 
Microbiology, Immunology, & Pathology Colorado State University, Fort Collins, CO 
Area:
Microbiology Biology, Cell Biology, Biochemistry

77 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Klever AM, Alexander KA, Almeida D, Anderson MZ, Ball RL, Beamer G, Boggiatto P, Buikstra JE, Chandler B, Claeys TA, Concha AE, Converse PJ, Derbyshire KM, Dobos KM, Dupnik KM, et al. The Many Hosts of Mycobacteria 9 (MHM9): A conference report. Tuberculosis (Edinburgh, Scotland). 142: 102377. PMID 37531864 DOI: 10.1016/j.tube.2023.102377  0.335
2022 Mehaffy C, Ryan JM, Kruh-Garcia NA, Dobos KM. Extracellular Vesicles in Mycobacteria and Tuberculosis. Frontiers in Cellular and Infection Microbiology. 12: 912831. PMID 35719351 DOI: 10.3389/fcimb.2022.912831  0.458
2022 Ryan JM, Dobos KM, Kruh-Garcia NA. Mycobacterium tuberculosis Extracellular Vesicle Enrichment through Size Exclusion Chromatography. Journal of Visualized Experiments : Jove. PMID 35661678 DOI: 10.3791/63895  0.336
2021 De P, Amin AG, Flores D, Simpson A, Dobos K, Chatterjee D. Structural Implications of Lipoarabinomannan Glycans from Global Clinical Isolates in Diagnosis of Mycobacterium tuberculosis Infection. The Journal of Biological Chemistry. 101265. PMID 34600887 DOI: 10.1016/j.jbc.2021.101265  0.388
2021 Lucas M, Ryan JM, Watkins J, Early K, Kruh-Garcia NA, Mehaffy C, Dobos KM. Extraction and Separation of Mycobacterial Proteins. Methods in Molecular Biology (Clifton, N.J.). 2314: 77-107. PMID 34235649 DOI: 10.1007/978-1-0716-1460-0_3  0.392
2021 Wallace E, Hendrickson D, Tolli N, Mehaffy C, Peña M, Nick JA, Knabenbaur P, Watkins J, Simpson A, Amin AG, Chatterjee D, Dobos KM, Lahiri R, Adams L, Strong M, et al. Culturing Mycobacteria. Methods in Molecular Biology (Clifton, N.J.). 2314: 1-58. PMID 34235647 DOI: 10.1007/978-1-0716-1460-0_1  0.321
2020 Mehaffy C, Kruh-Garcia NA, Graham B, Jarlsberg LG, Willyerd CE, Borisov A, Sterling TR, Nahid P, Dobos KM. Identification of peptides in serum extracellular vesicles from persons with latent tuberculosis infection. Journal of Clinical Microbiology. PMID 32245831 DOI: 10.1128/Jcm.00393-20  0.476
2019 Honda JR, Hess T, Carlson R, Kandasamy P, Nieto Ramirez LM, Norton GJ, Virdi R, Islam MN, Mehaffy C, Hasan NA, Epperson LE, Hesser D, Alper S, Strong M, Flores SC, ... ... Dobos KM, et al. Nontuberculous Mycobacteria Show Differential Infectivity and Use Phospholipids to Antagonize LL-37. American Journal of Respiratory Cell and Molecular Biology. PMID 31545652 DOI: 10.1165/Rcmb.2018-0278Oc  0.366
2019 Nieto Ramirez LM, Mehaffy C, Dobos KM. Protein profile of different cellular fractions from strains after exposure to isoniazid. Data in Brief. 24: 103953. PMID 31193076 DOI: 10.1016/J.Dib.2019.103953  0.402
2019 Mehaffy C, Belisle JT, Dobos KM. Mycobacteria and their sweet proteins: An overview of protein glycosylation and lipoglycosylation in M. tuberculosis. Tuberculosis (Edinburgh, Scotland). 115: 1-13. PMID 30948163 DOI: 10.1016/J.Tube.2019.01.001  0.532
2018 Decout A, Silva-Gomes S, Drocourt D, Blattes E, Rivière M, Prandi J, Larrouy-Maumus G, Caminade AM, Hamasur B, Källenius G, Kaur D, Dobos KM, Lucas M, Sutcliffe IC, Besra GS, et al. Deciphering the molecular basis of mycobacteria and lipoglycan recognition by the C-type lectin Dectin-2. Scientific Reports. 8: 16840. PMID 30443026 DOI: 10.1038/S41598-018-35393-5  0.443
2018 Keshavjee S, Amanullah F, Cattamanchi A, Chaisson R, Dobos KM, Fox GJ, Gendelman HE, Gordon R, Hesseling A, Hoi LV, Kampmann B, Kana B, Khuller G, Lewinsohn DM, Lewinsohn DA, et al. Moving Toward Tuberculosis Elimination: Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection. American Journal of Respiratory and Critical Care Medicine. PMID 30335466 DOI: 10.1164/Rccm.201806-1053Pp  0.491
2018 Nieto R LM, Mehaffy C, Islam MN, Fitzgerald B, Belisle J, Prenni J, Dobos KM. Biochemical characterization of isoniazid resistant : can the analysis of clonal strains reveal novel targetable pathways? Molecular & Cellular Proteomics : McP. PMID 29844232 DOI: 10.1074/Mcp.Ra118.000821  0.432
2018 Nahid P, Jarlsberg LG, Kato-Maeda M, Segal MR, Osmond DH, Gagneux S, Dobos K, Gold M, Hopewell PC, Lewinsohn DM. Interplay of strain and race/ethnicity in the innate immune response to M. tuberculosis. Plos One. 13: e0195392. PMID 29787561 DOI: 10.1371/Journal.Pone.0195392  0.408
2018 De P, McNeil M, Xia M, Boot CM, Hesser DC, Denef K, Rithner C, Sours T, Dobos KM, Hoft D, Chatterjee D. Structural determinants in a glucose-containing lipopolysaccharide from critical for inducing a subset of protective T cells. The Journal of Biological Chemistry. PMID 29716995 DOI: 10.1074/Jbc.Ra118.002582  0.305
2018 Diaz G, Bridges C, Lucas M, Cheng Y, Schorey JS, Dobos KM, Kruh-Garcia NA. Protein Digestion, Ultrafiltration, and Size Exclusion Chromatography to Optimize the Isolation of Exosomes from Human Blood Plasma and Serum. Journal of Visualized Experiments : Jove. PMID 29708539 DOI: 10.3791/57467  0.392
2018 Schultz TE, Wiesmüller KH, Lucas M, Dobos KM, Baxter AG, Blumenthal A. The N-terminal peptide moiety of the Mycobacterium tuberculosis 19 kDa lipoprotein harbors RP105-agonistic properties. Journal of Leukocyte Biology. PMID 29345364 DOI: 10.1002/Jlb.2Ma0517-190Rr  0.437
2017 Russell T, Green LS, Rice T, Kruh-Garcia NA, Dobos K, DeGroote MA, Hraha T, Sterling DG, Janjic N, Ochsner UA. Potential of High-Affinity, Slow Off-Rate Modified Aptamer (SOMAmer) Reagents for Mycobacterium tuberculosis Proteins as Tools for Infection Models and Diagnostic Applications. Journal of Clinical Microbiology. PMID 28794178 DOI: 10.1128/Jcm.00469-17  0.543
2017 Harriff MJ, Wolfe LM, Swarbrick G, Null M, Cansler ME, Canfield ET, Vogt T, Toren KG, Li W, Jackson M, Lewinsohn DA, Dobos KM, Lewinsohn DM. HLA-E Presents Glycopeptides from the Mycobacterium tuberculosis Protein MPT32 to Human CD8(+) T cells. Scientific Reports. 7: 4622. PMID 28676677 DOI: 10.1038/S41598-017-04894-0  0.662
2017 Mehaffy C, Dobos KM, Nahid P, Kruh-Garcia NA. Second generation multiple reaction monitoring assays for enhanced detection of ultra-low abundance Mycobacterium tuberculosis peptides in human serum. Clinical Proteomics. 14: 21. PMID 28592925 DOI: 10.1186/S12014-017-9156-Y  0.522
2016 Diaz G, Wolfe LM, Kruh-Garcia NA, Dobos KM. Changes in the Membrane-Associated Proteins of Exosomes Released from Human Macrophages after Mycobacterium tuberculosis Infection. Scientific Reports. 6: 37975. PMID 27897233 DOI: 10.1038/Srep37975  0.744
2016 Nieto R LM, Mehaffy C, Creissen E, Troudt J, Troy A, Bielefeldt-Ohmann H, Burgos M, Izzo A, Dobos KM. Virulence of Mycobacterium tuberculosis after Acquisition of Isoniazid Resistance: Individual Nature of katG Mutants and the Possible Role of AhpC. Plos One. 11: e0166807. PMID 27893795 DOI: 10.1371/Journal.Pone.0166807  0.332
2016 Xia M, Hesser DC, De P, Sakala IG, Spencer CT, Kirkwood JS, Abate G, Chatterjee D, Dobos KM, Hoft DF. A Subset of Protective γ9δ2 T cells is Activated by Novel Mycobacterial Lipid Components. Infection and Immunity. PMID 27297390 DOI: 10.1128/Iai.01322-15  0.462
2016 Nandakumar S, Kannanganat S, Dobos KM, Lucas M, Spencer JS, Amara RR, Plikaytis BB, Posey JE, Sable SB. Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis. Scientific Reports. 6: 25837. PMID 27173443 DOI: 10.1038/Srep25837  0.378
2016 Datta G, Nieto LM, Davidson RM, Mehaffy C, Pederson C, Dobos KM, Strong M. Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance. Tuberculosis (Edinburgh, Scotland). 98: 50-5. PMID 27156618 DOI: 10.1016/J.Tube.2016.02.004  0.356
2016 Nieto R LM, Mehaffy C, Dobos KM. Comparative proteomics between isogenic strains of Beijing genotype of Mycobacterium tuberculosis after acquisition of Isoniazid resistance. Proteomics. PMID 26929115 DOI: 10.1002/Pmic.201500403  0.518
2016 Nieto R LM, Mehaffy C, Dobos KM. Inside Front Cover: Comparing isogenic strains of Beijing genotypeMycobacterium tuberculosisafter acquisition of Isoniazid resistance: A proteomics approach Proteomics. 16: NA-NA. DOI: 10.1002/Pmic.201670091  0.305
2015 Randall LB, Dobos K, Papp-Wallace KM, Bonomo RA, Schweizer HP. Membrane-Bound PenA β-Lactamase of Burkholderia pseudomallei. Antimicrobial Agents and Chemotherapy. 60: 1509-14. PMID 26711764 DOI: 10.1128/Aac.02444-15  0.348
2015 Yu CH, Micaroni M, Puyskens A, Schultz TE, Yeo JC, Stanley AC, Lucas M, Kurihara J, Dobos KM, Stow JL, Blumenthal A. RP105 Engages Phosphatidylinositol 3-Kinase p110δ To Facilitate the Trafficking and Secretion of Cytokines in Macrophages during Mycobacterial Infection. Journal of Immunology (Baltimore, Md. : 1950). PMID 26371254 DOI: 10.4049/Jimmunol.1500017  0.324
2015 Wheat WH, Dhouib R, Angala SK, Larrouy-Maumus G, Dobos K, Nigou J, Spencer JS, Jackson M. The presence of a galactosamine substituent on the arabinogalactan of Mycobacterium tuberculosis abrogates full maturation of human peripheral blood monocyte-derived dendritic cells and increases secretion of IL-10. Tuberculosis (Edinburgh, Scotland). 95: 476-89. PMID 26048627 DOI: 10.1016/J.Tube.2015.04.002  0.359
2015 Honda JR, Hess T, Malcolm KC, Ovrutsky AR, Bai X, Irani VR, Dobos KM, Chan ED, Flores SC. Pathogenic nontuberculous mycobacteria resist and inactivate cathelicidin: implication of a novel role for polar mycobacterial lipids. Plos One. 10: e0126994. PMID 25993058 DOI: 10.1371/Journal.Pone.0126994  0.369
2015 Hoxmeier JC, Thompson BD, Broeckling CD, Small P, Foy BD, Prenni J, Dobos KM. Analysis of the metabolome of Anopheles gambiae mosquito after exposure to Mycobacterium ulcerans. Scientific Reports. 5: 9242. PMID 25784490 DOI: 10.1038/Srep09242  0.361
2015 Lucas MC, Wolfe LM, Hazenfield RM, Kurihara J, Kruh-Garcia NA, Belisle J, Dobos KM. Fractionation and analysis of mycobacterial proteins. Methods in Molecular Biology (Clifton, N.J.). 1285: 47-75. PMID 25779310 DOI: 10.1007/978-1-4939-2450-9_4  0.686
2015 Kruh-Garcia NA, Wolfe LM, Dobos KM. Deciphering the role of exosomes in tuberculosis. Tuberculosis (Edinburgh, Scotland). 95: 26-30. PMID 25496995 DOI: 10.1016/J.Tube.2014.10.010  0.62
2014 Kruh-Garcia NA, Wolfe LM, Chaisson LH, Worodria WO, Nahid P, Schorey JS, Davis JL, Dobos KM. Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS. Plos One. 9: e103811. PMID 25080351 DOI: 10.1371/Journal.Pone.0103811  0.75
2014 Perley CC, Frahm M, Click EM, Dobos KM, Ferrari G, Stout JE, Frothingham R. The human antibody response to the surface of Mycobacterium tuberculosis. Plos One. 9: e98938. PMID 24918450 DOI: 10.1371/Journal.Pone.0098938  0.352
2014 Wieczorek AE, Troudt JL, Knabenbauer P, Taylor J, Pavlicek RL, Karls R, Hess A, Davidson RM, Strong M, Bielefeldt-Ohmann H, Izzo AA, Dobos KM. HspX vaccination and role in virulence in the guinea pig model of tuberculosis. Pathogens and Disease. 71: 315-25. PMID 24616427 DOI: 10.1111/2049-632X.12147  0.421
2014 Kruh-Garcia NA, Murray M, Prucha JG, Dobos KM. Antigen 85 variation across lineages of Mycobacterium tuberculosis-implications for vaccine and biomarker success. Journal of Proteomics. 97: 141-50. PMID 23891556 DOI: 10.1016/J.Jprot.2013.07.005  0.452
2014 Kruh-Garcia NA, Wolfe LM, Chaisson LH, Worodria WO, Nahid P, Schorey JS, Davis JL, Dobos KM. Detection of Mycobacterium tuberculosis peptides in the exosomes of patients with active and latent M. tuberculosis infection using MRM-MS Plos One. 9. DOI: 10.1371/journal.pone.0103811  0.67
2013 Nandakumar S, Kannanganat S, Dobos KM, Lucas M, Spencer JS, Fang S, McDonald MA, Pohl J, Birkness K, Chamcha V, Ramirez MV, Plikaytis BB, Posey JE, Amara RR, Sable SB. O-mannosylation of the Mycobacterium tuberculosis adhesin Apa is crucial for T cell antigenicity during infection but is expendable for protection. Plos Pathogens. 9: e1003705. PMID 24130497 DOI: 10.1371/Journal.Ppat.1003705  0.418
2013 Wolfe LM, Veeraraghavan U, Idicula-Thomas S, Schürer S, Wennerberg K, Reynolds R, Besra GS, Dobos KM. A chemical proteomics approach to profiling the ATP-binding proteome of Mycobacterium tuberculosis. Molecular & Cellular Proteomics : McP. 12: 1644-60. PMID 23462205 DOI: 10.1074/Mcp.M112.025635  0.707
2012 Castillo EF, Dekonenko A, Arko-Mensah J, Mandell MA, Dupont N, Jiang S, Delgado-Vargas M, Timmins GS, Bhattacharya D, Yang H, Hutt J, Lyons CR, Dobos KM, Deretic V. Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation. Proceedings of the National Academy of Sciences of the United States of America. 109: E3168-76. PMID 23093667 DOI: 10.1073/Pnas.1210500109  0.415
2012 Bisson GP, Mehaffy C, Broeckling C, Prenni J, Rifat D, Lun DS, Burgos M, Weissman D, Karakousis PC, Dobos K. Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosis. Journal of Bacteriology. 194: 6441-52. PMID 23002228 DOI: 10.1128/Jb.01013-12  0.453
2012 Taylor JL, Wieczorek A, Keyser AR, Grover A, Flinkstrom R, Karls RK, Bielefeldt-Ohmann H, Dobos KM, Izzo AA. HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule. Immunology and Cell Biology. 90: 945-54. PMID 22801575 DOI: 10.1038/Icb.2012.34  0.439
2012 Yang H, Kruh-Garcia NA, Dobos KM. Purified protein derivatives of tuberculin--past, present, and future. Fems Immunology and Medical Microbiology. 66: 273-80. PMID 22762692 DOI: 10.1111/J.1574-695X.2012.01002.X  0.508
2012 Cho YS, Dobos KM, Prenni J, Yang H, Hess A, Rosenkrands I, Andersen P, Ryoo SW, Bai GH, Brennan MJ, Izzo A, Bielefeldt-Ohmann H, Belisle JT. Deciphering the proteome of the in vivo diagnostic reagent "purified protein derivative" from Mycobacterium tuberculosis. Proteomics. 12: 979-91. PMID 22522804 DOI: 10.1002/Pmic.201100544  0.547
2012 Mathema B, Kurepina N, Yang G, Shashkina E, Manca C, Mehaffy C, Bielefeldt-Ohmann H, Ahuja S, Fallows DA, Izzo A, Bifani P, Dobos K, Kaplan G, Kreiswirth BN. Epidemiologic consequences of microvariation in Mycobacterium tuberculosis. The Journal of Infectious Diseases. 205: 964-74. PMID 22315279 DOI: 10.1093/Infdis/Jir876  0.47
2012 Mehaffy MC, Kruh-Garcia NA, Dobos KM. Prospective on Mycobacterium tuberculosis proteomics. Journal of Proteome Research. 11: 17-25. PMID 21988637 DOI: 10.1021/Pr2008658  0.591
2012 Grover A, Troudt J, Arnett K, Izzo L, Lucas M, Strain K, McFarland C, Hall Y, McMurray D, Williams A, Dobos K, Izzo A. Assessment of vaccine testing at three laboratories using the guinea pig model of tuberculosis. Tuberculosis (Edinburgh, Scotland). 92: 105-11. PMID 21962569 DOI: 10.1016/J.Tube.2011.09.003  0.338
2011 Yang H, Troudt J, Grover A, Arnett K, Lucas M, Cho YS, Bielefeldt-Ohmann H, Taylor J, Izzo A, Dobos KM. Three protein cocktails mediate delayed-type hypersensitivity responses indistinguishable from that elicited by purified protein derivative in the guinea pig model of Mycobacterium tuberculosis infection. Infection and Immunity. 79: 716-23. PMID 21134965 DOI: 10.1128/Iai.00486-10  0.483
2010 Ioerger TR, Feng Y, Chen X, Dobos KM, Victor TC, Streicher EM, Warren RM, Gey van Pittius NC, Van Helden PD, Sacchettini JC. The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa. Bmc Genomics. 11: 670. PMID 21110864 DOI: 10.1186/1471-2164-11-670  0.37
2010 Kruh NA, Troudt J, Izzo A, Prenni J, Dobos KM. Portrait of a pathogen: the Mycobacterium tuberculosis proteome in vivo. Plos One. 5: e13938. PMID 21085642 DOI: 10.1371/Journal.Pone.0013938  0.481
2010 Wolfe LM, Mahaffey SB, Kruh NA, Dobos KM. Proteomic definition of the cell wall of Mycobacterium tuberculosis. Journal of Proteome Research. 9: 5816-26. PMID 20825248 DOI: 10.1021/Pr1005873  0.71
2010 Giri PK, Kruh NA, Dobos KM, Schorey JS. Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis-infected and culture filtrate protein-treated macrophages. Proteomics. 10: 3190-202. PMID 20662102 DOI: 10.1002/Pmic.200900840  0.551
2010 Ioerger TR, Feng Y, Ganesula K, Chen X, Dobos KM, Fortune S, Jacobs WR, Mizrahi V, Parish T, Rubin E, Sassetti C, Sacchettini JC. Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories. Journal of Bacteriology. 192: 3645-53. PMID 20472797 DOI: 10.1128/Jb.00166-10  0.343
2010 Mehaffy C, Hess A, Prenni JE, Mathema B, Kreiswirth B, Dobos KM. Descriptive proteomic analysis shows protein variability between closely related clinical isolates of Mycobacterium tuberculosis. Proteomics. 10: 1966-84. PMID 20217870 DOI: 10.1002/Pmic.200900836  0.487
2010 Deenadayalan A, Heaslip D, Rajendiran AA, Velayudham BV, Frederick S, Yang HL, Dobos K, Belisle JT, Raja A. Immunoproteomic identification of human T cell antigens of Mycobacterium tuberculosis that differentiate healthy contacts from tuberculosis patients. Molecular & Cellular Proteomics : McP. 9: 538-49. PMID 20031926 DOI: 10.1074/Mcp.M900299-Mcp200  0.547
2009 del Corral H, París SC, Marín ND, Marín DM, López L, Henao HM, Martínez T, Villa L, Barrera LF, Ortiz BL, Ramírez ME, Montes CJ, Oquendo MC, Arango LM, Riaño F, ... ... Dobos K, et al. IFNgamma response to Mycobacterium tuberculosis, risk of infection and disease in household contacts of tuberculosis patients in Colombia. Plos One. 4: e8257. PMID 20011589 DOI: 10.1371/Journal.Pone.0008257  0.501
2009 Tanne A, Ma B, Boudou F, Tailleux L, Botella H, Badell E, Levillain F, Taylor ME, Drickamer K, Nigou J, Dobos KM, Puzo G, Vestweber D, Wild MK, Marcinko M, et al. A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis. The Journal of Experimental Medicine. 206: 2205-20. PMID 19770268 DOI: 10.1084/Jem.20090188  0.43
2008 Marques MA, Neves-Ferreira AG, da Silveira EK, Valente RH, Chapeaurouge A, Perales J, da Silva Bernardes R, Dobos KM, Spencer JS, Brennan PJ, Pessolani MC. Deciphering the proteomic profile of Mycobacterium leprae cell envelope. Proteomics. 8: 2477-91. PMID 18563741 DOI: 10.1002/Pmic.200700971  0.521
2005 Kashyap RS, Dobos KM, Belisle JT, Purohit HJ, Chandak NH, Taori GM, Daginawala HF. Demonstration of components of antigen 85 complex in cerebrospinal fluid of tuberculous meningitis patients. Clinical and Diagnostic Laboratory Immunology. 12: 752-8. PMID 15939750 DOI: 10.1128/Cdli.12.6.752-758.2005  0.439
2005 Sable SB, Kumar R, Kalra M, Verma I, Khuller GK, Dobos K, Belisle JT. Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis. Infection and Immunity. 73: 3547-58. PMID 15908384 DOI: 10.1128/Iai.73.6.3547-3558.2005  0.539
2005 Raghunathan PL, Whitney EA, Asamoa K, Stienstra Y, Taylor TH, Amofah GK, Ofori-Adjei D, Dobos K, Guarner J, Martin S, Pathak S, Klutse E, Etuaful S, van der Graaf WT, van der Werf TS, et al. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 40: 1445-53. PMID 15844067 DOI: 10.1086/429623  0.325
2005 Mawuenyega KG, Forst CV, Dobos KM, Belisle JT, Chen J, Bradbury EM, Bradbury AR, Chen X. Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Molecular Biology of the Cell. 16: 396-404. PMID 15525680 DOI: 10.1091/Mbc.E04-04-0329  0.495
2005 Sable SB, Kumar R, Kalra M, Verma I, Khuller GK, Dobos K, Belisle JT. Peripheral Blood and Pleural Fluid Mononuclear Cell Responses to Low-Molecular-Mass Secretory Polypeptides of Mycobacterium tuberculosis in Human Models of Immunity to Tuberculosis Infection and Immunity. 73: 8456-8456. DOI: 10.1128/iai.73.12.8456.2005  0.374
2004 Stienstra Y, van der Werf TS, van der Graaf WT, Secor WE, Kihlstrom SL, Dobos KM, Asamoa K, Quarshi E, Etuaful SN, Klutse EY, King CH. Buruli ulcer and schistosomiasis: no association found. The American Journal of Tropical Medicine and Hygiene. 71: 318-21. PMID 15381813 DOI: 10.4269/Ajtmh.2004.71.318  0.345
2004 Marques MA, Espinosa BJ, Xavier da Silveira EK, Pessolani MC, Chapeaurouge A, Perales J, Dobos KM, Belisle JT, Spencer JS, Brennan PJ. Continued proteomic analysis of Mycobacterium leprae subcellular fractions. Proteomics. 4: 2942-53. PMID 15378742 DOI: 10.1002/Pmic.200400945  0.483
2004 Gehring AJ, Dobos KM, Belisle JT, Harding CV, Boom WH. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. Journal of Immunology (Baltimore, Md. : 1950). 173: 2660-8. PMID 15294983 DOI: 10.4049/Jimmunol.173.4.2660  0.358
2004 Turner J, Dobos KM, Keen MA, Frank AA, Ehlers S, Orme IM, Belisle JT, Cooper AM. A limited antigen-specific cellular response is sufficient for the early control of Mycobacterium tuberculosis in the lung but is insufficient for long-term survival. Infection and Immunity. 72: 3759-68. PMID 15213116 DOI: 10.1128/Iai.72.7.3759-3768.2004  0.43
2004 Dobos KM, Spencer JS, Orme IM, Belisle JT. Proteomic approaches to antigen discovery. Methods in Molecular Medicine. 94: 3-17. PMID 14959819 DOI: 10.1385/1-59259-679-7:3  0.486
2003 Gu S, Chen J, Dobos KM, Bradbury EM, Belisle JT, Chen X. Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Molecular & Cellular Proteomics : McP. 2: 1284-96. PMID 14532352 DOI: 10.1074/Mcp.M300060-Mcp200  0.552
2001 Dobos KM, Small PL, Deslauriers M, Quinn FD, King CH. Mycobacterium ulcerans cytotoxicity in an adipose cell model. Infection and Immunity. 69: 7182-6. PMID 11598099 DOI: 10.1128/Iai.69.11.7182-7186.2001  0.382
2000 Dobos KM, Spotts EA, Quinn FD, King CH. Necrosis of lung epithelial cells during infection with Mycobacterium tuberculosis is preceded by cell permeation. Infection and Immunity. 68: 6300-10. PMID 11035739 DOI: 10.1128/Iai.68.11.6300-6310.2000  0.423
2000 Dobos KM, Spotts EA, Marston BJ, Horsburgh CR, King CH. Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer disease Emerging Infectious Diseases. 6: 158-164. PMID 10756149 DOI: 10.3201/Eid0602.000208  0.31
1999 Dobos KM, Quinn FD, Ashford DA, Horsburgh CR, King CH. Emergence of a unique group of necrotizing mycobacterial diseases Emerging Infectious Diseases. 5: 367-378. PMID 10341173 DOI: 10.3201/Eid0503.990307  0.375
1996 Dobos KM, Khoo KH, Swiderek KM, Brennan PJ, Belisle JT. Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis Journal of Bacteriology. 178: 2498-2506. PMID 8626314 DOI: 10.1128/Jb.178.9.2498-2506.1996  0.345
1995 Dobos KM, Swiderek K, Khoo KH, Brennan PJ, Belisle JT. Evidence for glycosylation sites on the 45-kilodalton glycoprotein of Mycobacterium tuberculosis Infection and Immunity. 63: 2846-2853. PMID 7622204 DOI: 10.1128/Iai.63.8.2846-2853.1995  0.435
Show low-probability matches.